Techno Medica (6678) · InitiativeFirst statedLatest Earnings presentation (2026-05-26): "Worsened"
Achieving Management Conscious of Cost of Capital and Share Price
First written in FY2025. 1 of 2 entries say "Worsened", first in 2026-05-26. Latest entry: 2026-05-26.
2entries
2years
1from disclosures
How it moved
Same theme, other companies
Management Responses Focused on Cost of Capital and Share PriceA theme 71 companies write about · 1 as a headwind · 69 as a tailwind
Techno Medica moved to the "Worse" side of this theme in 2026.
0 other companies' latest entry also says "Worsened".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 71 companies compared. The sentences above are computed from all 71.Full recordFilings, disclosures and news, newest first
- 2026-05-26WorsenedEarnings presentation
「ROE remained above 7% through the fiscal year ended March 2026, but is expected to decline to 5.5% in the fiscal year ending March 2027 due to a decrease in net income.」
The company expects ROE to decline to 5.5% in the fiscal year ending March 2027, below the 7% cost of shareholders' equity. It identified earnings recovery, reducing equity through shareholder returns and improving total asset turnover as countermeasures. - FY2025First statedAnnual report
「Response to achieving management that is conscious of the cost of capital and share price」
For the first time, the company explicitly identified measures to achieve management that is conscious of the cost of capital and share price as a topic for consideration by the board of directors.